Chapter 13

Erythropoietin – A Possible Adjunctive Therapy for Cerebral Malaria

Casper Hempel and Jørgen A.L. Kurtzhals


Cerebral malaria a severe complication of an infection caused by the parasite Plasmodium falciparum. It is an acute encephalopathy and currently the adjunctive therapy supporting the anti-malarial treatment consists of glucose and oxygen supplementation. Wishing to improve the adjunctive therapy, we have studied the use of erythropoietin (EPO) and its possible neuroprotective effects in a murine model of cerebral malaria. EPO reduces the mortality and neuropathology in this model and is well tolerated. Our research is discussed in relation to the current literature and the potential as using EPO as adjunct therapy in humans is discussed.

Total Pages: 232-254 (23)

Purchase Chapter  Book Details


.Frontiers in Anti-infective Drug Discovery.
.Frontiers in Drug Design and Discovery.
.In Silico and In vitro Approaches to Screen the Anti-TB Activity of Benzothiazole Analogs.
.Anti-Obesity Drug Discovery and Development.